Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.

Détails

ID Serval
serval:BIB_87F4CD45B199
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature.
Périodique
Critical reviews in oncology/hematology
Auteur(s)
Alongi F., Arcangeli S., De Bari B., Giaj-Levra N., Fiorentino A., Mazzola R., Trovò M.
ISSN
1879-0461 (Electronic)
ISSN-L
1040-8428
Statut éditorial
Publié
Date de publication
03/2017
Peer-reviewed
Oui
Volume
112
Pages
67-71
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Small cell lung cancer (SCLC) is relative rare histology in lung cancer patients. The standard treatment, in patients with an intra-thoracic disease, is represented by the use of concurrent chemo-radiotherapy; while patients with early SCLC stage, surgical resection could be recommended. Stereotactic body radiotherapy (SBRT) is a recently introduced technique allowing the delivery of very high radiation doses to limited target volumes and it is considered the standard approach in the treatment of not operable stage I Non Small-Cell Lung Cancer (NSCLC). The successful role option of SBRT in early NSCLC in terms of local control and toxicity profile opened the issue in the use of this approach in early stage small cell lung cancer (SCLC). Aim of this review is to discuss the current literature in the safety and efficacy of SBRT in the treatment of patients with stage I SCLC.

Pubmed
Web of science
Création de la notice
28/03/2017 16:43
Dernière modification de la notice
20/08/2019 14:47
Données d'usage